MHCombiotic Inc. (MHC) is a Calgary-based biotech company tackling antimicrobial resistance (AMR) through groundbreaking research and innovation. Founded by Dr. Ali Pormohammad, Professor R J Turner, and CCrest Laboratory, MHC emerged from postdoctoral research at the University of Calgary and has collaborated with Harvard University, the University of Barcelona, and top research institutions across Canada and the U.S. Over three years, the team screened 18,000+ novel formulations, leading to the development of Combiotic™, a breakthrough product validated by FDA and Health Canada-approved labs.